INHA and tuberculosis: HCF 5, HCF 2, and HCF 4 had the highest number of mutations in the inhA gene (Figure 4); this means INH can still be used but in high doses for the treatment of TB in patients from the catchment areas of the clinic, however, due to development of mutations in genes during treatment, treatment management is needed.